Amgen (AMGN)

$310.88 1.50 (0.48%)

16:00 EDT AMGN Stock Quote Delayed 30 Minutes

Hot Stocks: The 3 Best Opportunities for Investing in the Dow

By Josh Enomoto, InvestorPlace Contributor Mar 20, 2024

While investing in Dow stocks – that is, the 30 companies making up the Dow Jones Industrial Average – might seem incredibly boring, investors shouldn’t…

Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks

It’s Time! 3 Dodgy Pharma Stocks to Sell in February

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 1.27M

Day's Range $308.57 - $313.41

52-Week Range $218.44 - $329.72

Dividend & Yield $8.52 (2.74%)

AMGN Stock Predictions, Articles, and Amgen News

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

By Alex Sirois, InvestorPlace Contributor Feb 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.

3 Fantastic Dow Stocks to Buy in February 2024

By Rich Duprey, InvestorPlace Contributor Feb 5, 2024

The venerable index is more representative of today's economy and these three Dow stocks to buy are brightly shining component stars.

Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs

By Larry Ramer, InvestorPlace Contributor Jan 25, 2024

The best weight-loss drug stocks are improving the drugs or developing new, potentially superior, weight-loss treatments.

Dogs of the Dow: January’s Top 3 Picks to Buy for Big Gains

By Larry Ramer, InvestorPlace Contributor Jan 10, 2024

Buying Dogs of the Dow stocks is an attractive strategy that involves buying stocks with high dividend yields that have often underperformed.

Why Is Xeris Biopharma (XERS) Stock Up 12% Today?

By William White, InvestorPlace Writer Jan 10, 2024

Xeris Biopharma stock is rising higher on Wednesday as investors in XERS shares react to a new exclusive worldwide license agreement.

3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’

By TradeSmith Research Staff Dec 21, 2023

It's now time to take a look at these three biotech stocks to buy, as each one is currently within TradeSmith's "Green Zone."

Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts

By Chris MacDonald, InvestorPlace Contributor Oct 24, 2023

Investors appear to be viewing Amgen's recent job cuts as a positive today, with buying pressure resulting in a 1% move higher in AMGN stock.

3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals

By Larry Ramer, InvestorPlace Contributor Sep 28, 2023

The demand for obesity drugs is intense and is likely to only greatly increase going forward, since over 40% of Americans were obese in 2020.

The 3 Most Undervalued Biotech Stocks to Buy in September 2023

By Joel Baglole, InvestorPlace Contributor Sep 12, 2023

While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners.

These Are the ONLY 3 Biotech Stocks to Consider in August 2023

By Muslim Farooque, InvestorPlace Contributor Aug 21, 2023

These biotech stocks to buy represent tremendous bets and are essentially fueling innovation and portfolio growth at the same time.

The 3 Best Biotech Stocks to Buy in August

By Jeremy Flint, InvestorPlace Contributor Aug 9, 2023

Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news.

The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023

By Charles Munyi, InvestorPlace Contributor Jul 21, 2023

Trading below a 15 forward price-to-earnings, these undervalued pharma stocks offer opportunities in an overbought market.

3 Biotech Stocks for Getting Rich in 2023

By Noah Bolton, InvestorPlace Contributor Jul 18, 2023

These 3 biotech stocks have seen stable or growing revenue this year. This makes them companies to keep on your watchlist.

3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025

By Chris Markoch, InvestorPlace Contributor Jul 5, 2023

In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025

How to Retire Rich: Biotech Stocks Edition

By Josh Enomoto, InvestorPlace Contributor Jun 18, 2023

Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.

3 Undervalued Biotech Stocks to Buy Before They Blast Off

By Chris Markoch, InvestorPlace Contributor Jun 2, 2023

Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.

3 Dogs of the Dow for High-Yield Investors

By Bob Ciura, Sure Dividend May 25, 2023

These Dogs of the Dow boast high dividend yields and will hold up well in a potential recession. Let's take a look.

HZNP Stock Alert: Why Is Horizon Therapeutics Plunging Today

By Larry Ramer, InvestorPlace Contributor May 16, 2023

Horizon Therapeutics (HZNP) stock is sinking after the FTC reportedly decided to sue to block its merger with Amgen (AMGN).

7 Blue-Chip Stocks to Buy in May 2023

By Josh Enomoto, InvestorPlace Contributor May 4, 2023

While not the most exciting sector available, rising fears in the market incentivizes the best blue-chip stocks to buy.

7 Dividend Stocks to Buy That Are Backed by Strong Cash Flows

By Chris Markoch, InvestorPlace Contributor Apr 16, 2023

Cash is king and this article highlights seven dividend stocks with strong cash flows and an emphasis on free cash flow

Amgen (AMGN)

Hot Stocks: The 3 Best Opportunities for Investing in the Dow

Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks

It’s Time! 3 Dodgy Pharma Stocks to Sell in February

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Amgen (AMGN)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AMGN Stock Predictions, Articles, and Amgen News

Subscriber Sign in